Since previous cell-based experiments indicated that silencing of ARSB and the associated increase in chondroitin 4-sulfation enhanced the binding of SHP-2 (PTPN11) with C4S and reduced the SHP2 activity, the impact of exogenous ARSB on SHP2 in the tumor tissue was addressed. Here, ARSB is linked to neoplasm.